Experimental drug shows early promise against inherited form of ALS, trial indicates
Wednesday, July 8, 2020 - 22:00
in Health & Medicine
A clinical trial has found evidence that the experimental drug tofersen lowers levels of a disease-causing protein in people with an inherited form of amyotrophic lateral sclerosis, or ALS, caused by mutations in the gene SOD1.